Molecular Characterization of the viaB Locus Encoding the Biosynthetic Machinery for Vi Capsule Formation in Salmonella Typhi

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wetter, Michael ^a   Goulding, David ^b   Pickard, Derek ^b   Kowarik, Michael ^a   Waechter, Charles J ^c   Dougan, Gordon ^b   Wacker, Michael ^a  

^a GlycoVaxyn AG   (Switzerland)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; POLYMER; UNCLASSIFIED DRUG; VI CAPSULAR POLYSACCHARIDE;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ANALYSIS; MOLECULAR CLONING; MUTANT; NONHUMAN; PHENOTYPE; PROTEIN SYNTHESIS; SALMONELLA TYPHI; TRANSPOSON; TVIA GENE; TVIB GENE; TVIE GENE; VEXA GENE; VEXBC GENE; VEXD GENE; VEXE GENE; VIAB GENE; WILD TYPE;

CARBOHYDRATE SEQUENCE; ESCHERICHIA COLI; GENES, BACTERIAL; MUTATION; POLYSACCHARIDES, BACTERIAL; SALMONELLA TYPHI; VIRULENCE;

ESCHERICHIA COLI; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

EID: 84866640576     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045609     Document Type: Article

References (46)

1. Looney RJ, Steigbigel RT, (1986) Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J Lab Clin Med 108: 506-516.
2. Robbins JD, Robbins JB, (1984) Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 150: 436-449.
3. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, et al. (1970) Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med 283: 739-746.
4. Hone DM, Attridge SR, Forrest B, Morona R, Daniels D, et al. (1988) A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect Immun 56: 1326-1333.
5. Arya SC, (2002) Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China. J Infect Dis 185: 845 author reply 845-846.
6. Engels EA, Falagas ME, Lau J, Bennish ML, (1998) Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. Bmj 316: 110-116.
7. Szu SC, Li XR, Stone AL, Robbins JB, (1991) Relation between structure and immunologic properties of the Vi capsular polysaccharide. Infect Immun 59: 4555-4561.
8. Szu SC, Bystricky S, (2003) Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella typhi. Methods Enzymol 363: 552-567.
9. Hashimoto Y, Ezaki T, Li N, Yamamoto H, (1991) Molecular cloning of the ViaB region of Salmonella typhi. FEMS Microbiol Lett 69: 53-56.
10. Pickard D, Wain J, Baker S, Line A, Chohan S, et al. (2003) Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J Bacteriol 185: 5055-5065.
11. Whitfield C, (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75: 39-68.
12. Houng HS, Noon KF, Ou JT, Baron LS, (1992) Expression of Vi antigen in Escherichia coli K-12: characterization of ViaB from Citrobacter freundii and identity of ViaA with RcsB. J Bacteriol 174: 5910-5915.
13. Virlogeux I, Waxin H, Ecobichon C, Lee JO, Popoff MY, (1996) Characterization of the rcsA and rcsB genes from Salmonella typhi: rcsB through tviA is involved in regulation of Vi antigen synthesis. J Bacteriol 178: 1691-1698.
14. Pickard D, Li J, Roberts M, Maskell D, Hone D, et al. (1994) Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect Immun 62: 3984-3993.
15. Hashimoto Y, Li N, Yokoyama H, Ezaki T, (1993) Complete nucleotide sequence and molecular characterization of ViaB region encoding Vi antigen in Salmonella typhi. J Bacteriol 175: 4456-4465.
16. Arricau N, Hermant D, Waxin H, Ecobichon C, Duffey PS, et al. (1998) The RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity. Mol Microbiol 29: 835-850.
17. Virlogeux I, Waxin H, Ecobichon C, Popoff MY, (1995) Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. Microbiology 141 (Pt 12) (): 3039-3047.
18. Zhang H, Zhou Y, Bao H, Liu HW, (2006) Vi antigen biosynthesis in Salmonella typhi: characterization of UDP-N-acetylglucosamine C-6 dehydrogenase (TviB) and UDP-N-acetylglucosaminuronic acid C-4 epimerase (TviC). Biochemistry 45: 8163-8173.
19. Cuthbertson L, Mainprize IL, Naismith JH, Whitfield C, (2009) Pivotal roles of the outer membrane polysaccharide export and polysaccharide copolymerase protein families in export of extracellular polysaccharides in gram-negative bacteria. Microbiol Mol Biol Rev 73: 155-177.
20. Dong C, Beis K, Nesper J, Brunkan-Lamontagne AL, Clarke BR, et al. (2006) Wza the translocon for E. coli capsular polysaccharides defines a new class of membrane protein. Nature 444: 226-229.
21. Sathiyamoorthy K, Mills E, Franzmann TM, Rosenshine I, Saper MA, (2011) The crystal structure of Escherichia coli group 4 capsule protein GfcC reveals a domain organization resembling that of Wza. Biochemistry 50: 5465-5476.
22. Bliss JM, Silver RP, (1996) Coating the surface: a model for expression of capsular polysialic acid in Escherichia coli K1. Mol Microbiol 21: 221-231.
23. Craigie J, Brandon KF, (1936) Bacteriophage specific for the O-resistant V form of B. typhosus. J Pathol Bacteriol 43: 233-248.
24. Craigie J, Yen CH, (1937) V bacteriophages for B. typhosus. Trans R Soc Can 5: 79-87.
25. Craigie J, Yen CH, (1938) The demonstration of types of B. typhosus by means of preparations of type II Vi phage. I. Principles and technique. Can Public Health J 29: 448-463.
26. Desranleau JM, (1949) Progress in the treatment of typhoid fever with Vi bacteriophages. Can J Public Health 40: 473-478.
27. Brandis H, Imamura PS, (1956) [Comparative studies of Vi-bacteriophages]. Z Hyg Infektionskr 143: 50-61.
28. Qadri A, Ghosh S, Talwar GP, (1990) Monoclonal antibodies against two discrete determinants on Vi capsular polysaccharide. J Immunoassay 11: 235-250.
29. Taylor K, (1965) Enzymatic deacetylation of Vi-polysaccharide by Vi-phage. II. Biochem Biophys Res Commun 20: 752-756.
30. Hestrin S, (1949) The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J Biol Chem 180: 249-261.
31. Bergfeld AK, Claus H, Vogel U, Muhlenhoff M, (2007) Biochemical characterization of the polysialic acid-specific O-acetyltransferase NeuO of Escherichia coli K1. J Biol Chem 282: 22217-22227.
32. Johnson EM, Baron LS, (1969) Genetic transfer of the Vi antigen from Salmonella typhosa to Escherichia coli. J Bacteriol 99: 358-359.
33. Pickard D, Toribio AL, Petty NK, van Tonder A, Yu L, et al. A conserved acetyl esterase domain targets diverse bacteriophages to the Vi capsular receptor of Salmonella enterica serovar Typhi. J Bacteriol 192: 5746-5754.
34. Friedman AM, Long SR, Brown SE, Buikema WJ, Ausubel FM, (1982) Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants. Gene 18: 289-296.
35. Nair S, Alokam S, Kothapalli S, Porwollik S, Proctor E, et al. (2004) Salmonella enterica serovar Typhi strains from which SPI7, a 134-kilobase island with genes for Vi exopolysaccharide and other functions, has been deleted. J Bacteriol 186: 3214-3223.
36. Annunziato PW, Wright LF, Vann WF, Silver RP, (1995) Nucleotide sequence and genetic analysis of the neuD and neuB genes in region 2 of the polysialic acid gene cluster of Escherichia coli K1. J Bacteriol 177: 312-319.
37. Troy FA 2nd, (1992) Polysialylation: from bacteria to brains. Glycobiology 2: 5-23.
38. Pavelka MS Jr, Hayes SF, Silver RP, (1994) Characterization of KpsT, the ATP-binding component of the ABC-transporter involved with the export of capsular polysialic acid in Escherichia coli K1. J Biol Chem 269: 20149-20158.
39. Rigg GP, Barrett B, Roberts IS, (1998) The localization of KpsC, S and T, and KfiA, C and D proteins involved in the biosynthesis of the Escherichia coli K5 capsular polysaccharide: evidence for a membrane-bound complex. Microbiology 144 (Pt 10) (): 2905-2914.
40. Steenbergen SM, Vimr ER, (2008) Biosynthesis of the Escherichia coli K1 group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment. Mol Microbiol 68: 1252-1267.
41. Bronner D, Sieberth V, Pazzani C, Roberts IS, Boulnois GJ, et al. (1993) Expression of the capsular K5 polysaccharide of Escherichia coli: biochemical and electron microscopic analyses of mutants with defects in region 1 of the K5 gene cluster. J Bacteriol 175: 5984-5992.
42. Wunder DE, Aaronson W, Hayes SF, Bliss JM, Silver RP, (1994) Nucleotide sequence and mutational analysis of the gene encoding KpsD, a periplasmic protein involved in transport of polysialic acid in Escherichia coli K1. J Bacteriol 176: 4025-4033.
43. Bliss JM, Garon CF, Silver RP, (1996) Polysialic acid export in Escherichia coli K1: the role of KpsT, the ATP-binding component of an ABC transporter, in chain translocation. Glycobiology 6: 445-452.
44. Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM, (1991) Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9: 810-816.
45. Demil P, D'Hondt E, Van Hoecke C, (2003) Salmonella Typhi vaccine compositions. EP 1 107 787 B1.
46. Jansen AM, Hall LJ, Clare S, Goulding D, Holt KE, et al. A Salmonella Typhimurium-Typhi genomic chimera: a model to study Vi polysaccharide capsule function in vivo. PLoS Pathog 7: e1002131.